Fig. 3From: Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United StatesProbabilistic sensitivity analysis of symptom management (red) compared to pirfenidone (green) and nintedanib (blue). X-axis is our WTP. Y-axis is the proportion of times a specific treatment strategy was cost effective among 10,000 simulationsBack to article page